Risk factors and predictors of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii mortality in critically ill bacteraemic patients over a 6-year period (2010-15): antibiotics do matter
- PMID: 28758623
- DOI: 10.1099/jmm.0.000538
Risk factors and predictors of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii mortality in critically ill bacteraemic patients over a 6-year period (2010-15): antibiotics do matter
Abstract
Purpose. Acinetobacter baumannii and Pseudomonas aeruginosa provoke serious infections, especially in intensive care unit (ICU) patients.Methodology. The risk factors and predictors of mortality for P. aeruginosa (n=84; 46 carbapenem-resistant) and A. baumannii (n=129; all carbapenem-resistant) bloodstream infections (BSIs) in an ICU were evaluated. Antibiotic susceptibility testing was performed using the agar disk diffusion method according to EUCAST guidelines. The minimum inhibitory concentration was determined by a gradient method (Etest). Multilocus sequence typing (MLST) was performed for P. aeruginosa during the carbapenem-resistant outbreak in 2014. Epidemiological data were collected from the patients' chart reviews.Results/Key findings. Hospitalization during the summer months, prior KPC-producing Klebsiella pneumoniae (KPC-Kp) BSI, and the administration of tigecycline, aminoglycosides and cortisone were independently associated with P. aeruginosa BSIs. MLST revealed the dissemination of clone ST227, including carbapenem-resistant P. aeruginosa strains. Hospitalization during the summer months, prior KPC-Kp BSI, and the administration of antibiotics, carbapenem and cortisone were independently associated with A. baumannii BSIs. The 30-day mortality rate for P. aeruginosa and A. baumannii BSI was 45.2 and 39.5 %, respectively. Sequential organ failure assessment (SOFA) score at onset, septic shock, age, and prior KPC-Kp BSI were significantly associated with P. aeruginosa BSI mortality. The administration of at least one active antibiotic was identified as a predictor of a good prognosis. Septic shock and simplified acute physiology score (SAPS) II at onset were independently associated with A. baumannii BSI mortality. The administration of at least one active antibiotic and colistin-vancomycin co-administration were identified as predictors of a good prognosis.Conclusion. KPC-Kp infection predisposes ICU patients to BSI by either A. baumannii or P. aeruginosa. The administration of at least one active antibiotic leads to better survival rates.
Keywords: bloodstream infection; carbapenem resistance; colistin-vancomycin co-administration; intensive care unit (ICU); seasonality; tigecycline.
Similar articles
-
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.Scand J Infect Dis. 2014 Sep;46(9):642-8. doi: 10.3109/00365548.2014.923106. Epub 2014 Jul 14. Scand J Infect Dis. 2014. PMID: 25017796
-
Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.Antimicrob Agents Chemother. 2018 May 25;62(6):e02562-17. doi: 10.1128/AAC.02562-17. Print 2018 Jun. Antimicrob Agents Chemother. 2018. PMID: 29555630 Free PMC article.
-
Epidemiology of Klebsiella pneumoniae bloodstream infections in a teaching hospital: factors related to the carbapenem resistance and patient mortality.Antimicrob Resist Infect Control. 2016 Nov 17;5:48. doi: 10.1186/s13756-016-0145-0. eCollection 2016. Antimicrob Resist Infect Control. 2016. PMID: 27891222 Free PMC article.
-
Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis.Int J Infect Dis. 2018 Nov;76:48-57. doi: 10.1016/j.ijid.2018.05.017. Epub 2018 Jun 2. Int J Infect Dis. 2018. PMID: 29870795
-
Bloodstream infections in the era of the COVID-19 pandemic: Changing epidemiology of antimicrobial resistance in the intensive care unit.J Intensive Med. 2024 Mar 27;4(3):269-280. doi: 10.1016/j.jointm.2023.12.004. eCollection 2024 Jul. J Intensive Med. 2024. PMID: 39035613 Free PMC article. Review.
Cited by
-
Clinical Prediction of Secondary Bloodstream Infections in Patients with Cerebral Infarction: A Nomogram-Driven Risk Assessment Model Based on LASSO Regression.Infect Drug Resist. 2025 Jul 25;18:3677-3687. doi: 10.2147/IDR.S529528. eCollection 2025. Infect Drug Resist. 2025. PMID: 40741529 Free PMC article.
-
Clinical Characteristics and Prognosis Analysis of Acinetobacter baumannii Bloodstream Infection Based on Propensity Matching.Infect Drug Resist. 2022 Nov 30;15:6963-6974. doi: 10.2147/IDR.S387898. eCollection 2022. Infect Drug Resist. 2022. PMID: 36474906 Free PMC article.
-
Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases.Front Cell Infect Microbiol. 2023 Jun 21;13:1156651. doi: 10.3389/fcimb.2023.1156651. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37415825 Free PMC article.
-
Determinants of Mortality in Patients with Nosocomial Acinetobacter baumannii Bacteremia in Southwest China: A Five-Year Case-Control Study.Can J Infect Dis Med Microbiol. 2018 Jun 3;2018:3150965. doi: 10.1155/2018/3150965. eCollection 2018. Can J Infect Dis Med Microbiol. 2018. PMID: 29973964 Free PMC article.
-
A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.Ann Clin Microbiol Antimicrob. 2019 Jul 2;18(1):19. doi: 10.1186/s12941-019-0319-8. Ann Clin Microbiol Antimicrob. 2019. PMID: 31266519 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources